To Be Continued
December 7, 2019
Hovione’s New Jersey-based site has provided process development and small volume API manufacturing since 2002. In the years since its inception, the site has expanded its portfolio to include particle engineering capabilities and the handling of highly potent compounds. And in 2017, the company introduced continuous drug product manufacturing to its roster. Here, we speak with experts at Hovione, including Alexandra Adao (Head of Quality Assurance Continuous Manufacturing), Jose Santos (Head of Drug Product Continuous Manufacturing), Nuno Matos (Head of Quality Systems Management), and Sarang Oka (Process Development Engineer), about the promises and pitfalls of continuous manufacturing and how the facility is faring since it became operational.
0 min read
